Stage IIB Colon Cancer AJCC v7: Clinical Trials

3 trials for Stage IIB Colon Cancer AJCC v7, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Early Phase 11Completed 1

Follow Stage IIB Colon Cancer AJCC v7: new trials by email Literature Review of Stage IIB Colon Cancer AJCC v7 trials Research Report on Stage IIB Colon Cancer AJCC v7

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
American Ginseng, Laboratory Biomarker Analysis, Placebo - Cancer Survivor, Stage I Breast Cancer AJCC v7
Early Phase 1CompletedMayo Clinic22019-03-012023-01-05
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Bevacizumab, Fluorouracil, Leucovorin - Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7
Phase 3CompletedNational Cancer Institute (NCI)24312005-09-062026-08-25
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
Bevacizumab, Fluorouracil, Leucovorin Calcium - Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7
Phase 3CompletedNational Cancer Institute (NCI)27102004-09-152019-07-30

Narrower conditions

Colonic Neoplasms (3)  ·  Breast Neoplasms (1)

Broader conditions

Colonic Diseases (3)  ·  Colorectal Neoplasms (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Gastrointestinal Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Intestinal Diseases (3)  ·  Intestinal Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Breast Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Bevacizumab (2)  ·  Disulfides (2)  ·  Fluorouracil (2)  ·  Immunoglobulin G (2)  ·  Leucovorin (2)  ·  Oxaliplatin (2)  ·  dehydroftorafur (2)  ·  Asian ginseng (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Mayo Clinic (1)

Countries

United States (3)  ·  Canada (1)  ·  Peru (1)  ·  Puerto Rico (1)  ·  South Africa (1)

Top investigators

Al B Benson (1)  ·  Carmen J Allegra (1)  ·  Noel Arring (1)

Results publications

PMID 21997132, PMID 23233715, PMID 28006055, PMID 31268130, PMID 31811950, PMID 33356421, PMID 38315963

NIH funding

U10CA012027 (1), U10CA021115 (1), U10CA180820 (1)